Diagnostic Immunophenotype of Acute Promyelocytic Leukemia Before and Early During Therapy With All-trans Retinoic Acid | Zendy

Pedro Horna | Zendy; Ling Zhang | Zendy; Eduardo M. Sotomayor | Zendy; Jeffrey E. Lancet | Zendy; Lynn C. Moscinski | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Diagnostic Immunophenotype of Acute Promyelocytic Leukemia Before and Early During Therapy With All-trans Retinoic Acid

Author(s) -

Pedro Horna,

Ling Zhang,

Eduardo M. Sotomayor,

Jeffrey E. Lancet,

Lynn C. Moscinski

Publication year - 2014

Publication title -

american journal of clinical pathology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.859

H-Index - 128

eISSN - 1943-7722

pISSN - 0002-9173

DOI - 10.1309/ajcppokehbp53zhv

Subject(s) - acute promyelocytic leukemia , medicine , immunophenotyping , cd117 , tretinoin , cd34 , flow cytometry , cd11c , myeloid leukemia , retinoic acid , leukemia , immunology , gastroenterology , stem cell , biology , biochemistry , genetics , gene , phenotype

To study the immunophenotypic changes of acute promyelocytic leukemia (APL) in patients who recently received all-trans retinoic acid (ATRA) and to assess the diagnostic utility of flow cytometry in this setting.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research